WEDNESDAY, July 2 (HealthDay News) -- Drugs designed to control type 2 diabetes should be subjected to more thorough safety reviews to ensure they don't raise the risk of heart problems, U.S. Food and Drug Administration advisers said Wednesday.

The panel of outside experts voted 14-to-2, at the end of a two-day meeting, to recommend that all makers of these drugs conduct long-term cardiovascular trials, even if the drugs show no signs of heart problems in initial trials.

By Amanda Gardner
EmpowHer's HealthDay Reporter

MONDAY, April 28 (HealthDay News) -- Avandia and Fosamax, widely prescribed drugs used to treat two common health conditions, show further evidence of being linked to adverse events.

One study finds that long-term use of thiazolidinediones -- a family of diabetes drugs that includes blockbuster Avandia -- appears to be linked with an increased risk for bone fractures.